Chromosome aberrations in solid tumors (original) (raw)

• Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57–70 (2000).
  Article CAS PubMed Google Scholar
• Hampton, G.M. et al. Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc. Natl. Acad. Sci. USA 93, 6704–6709 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Kallioniemi, A. et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258, 818–821 (1992).
  Article CAS PubMed Google Scholar
• Pinkel, D. et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20, 207–211 (1998).
  Article CAS PubMed Google Scholar
• Solinas-Toldo, S. et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20, 399–407 (1997).
  Article CAS PubMed Google Scholar
• Pollack, J.R. et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. USA 99, 12963–12968 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Schrock, E. et al. Multicolor spectral karyotyping of human chromosomes. Science 273, 494–497 (1996).
  Article CAS PubMed Google Scholar
• Fauth, C. & Speicher, M.R. Classifying by colors: FISH-based genome analysis. Cytogenet. Cell. Genet. 93, 1–10 (2001).
  Article CAS PubMed Google Scholar
• Speicher, M.R. & Ward, D.C. The coloring of cytogenetics. Nat. Med. 2, 1046–1048 (1996).
  Article CAS PubMed Google Scholar
• Lichter, P. Multicolor FISHing: what's the catch? Trends Genet. 13, 475–479 (1997).
  Article CAS PubMed Google Scholar
• Imoto, H. et al. Direct determination of _Not_I cleavage sites in the genomic DNA of adult mouse kidney and human trophoblast using whole-range restriction landmark genomic scanning. DNA Res. 1, 239–243 (1994).
  Article CAS PubMed Google Scholar
• Lisitsyn, N. & Wigler, M. Cloning the differences between two complex genomes. Science 259, 946–951 (1993).
  Article CAS PubMed Google Scholar
• Haigis, K.M., Caya, J.G., Reichelderfer, M. & Dove, W.F. Intestinal adenomas can develop with a stable karyotype and stable microsatellites. Proc. Natl. Acad. Sci. USA 99, 8927–8931 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Haigis, K.M. & Dove, W.F. A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity. Nat. Genet. 33, 33–39 (2003).
  Article CAS PubMed Google Scholar
• Sieber, O.M. et al. Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC. Proc. Natl. Acad. Sci. USA 99, 16910–16915 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Guan, X.Y., Meltzer, P.S., Dalton, W.S. & Trent, J.M. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nat. Genet. 8, 155–161 (1994).
  Article CAS PubMed Google Scholar
• Knuutila, S., Autio, K. & Aalto, Y. Online access to CGH data of DNA sequence copy number changes. Am. J. Pathol. 157, 689 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Lassus, H. et al. Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4. Lab. Invest. 81, 517–526 (2001).
  Article CAS PubMed Google Scholar
• Smith, J.S. et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 18, 4144–4152 (1999).
  Article CAS PubMed Google Scholar
• Bocker, T., Ruschoff, J. & Fishel, R. Molecular diagnostics of cancer predisposition: hereditary non-polyposis colorectal carcinoma and mismatch repair defects. Biochim. Biophys. Acta 1423, O1–O10 (1999).
  CAS PubMed Google Scholar
• Muleris, M., Dutrillaux, A.M., Olschwang, S., Salmon, R.J. & Dutrillaux, B. Predominance of normal karyotype in colorectal tumors from hereditary non-polyposis colorectal cancer patients. Genes Chromosomes Cancer 14, 223–226 (1995).
  Article CAS PubMed Google Scholar
• Muleris, M., Salmon, R.J. & Dutrillaux, B. Cytogenetics of colorectal adenocarcinomas. Cancer Genet. Cytogenet. 46, 143–156 (1990).
  Article CAS PubMed Google Scholar
• Soulie, P. et al. TP53 status and gene amplification in human colorectal carcinomas. Cancer Genet. Cytogenet. 115, 118–122 (1999).
  Article CAS PubMed Google Scholar
• Remvikos, Y. et al. DNA-repeat instability is associated with colorectal cancers presenting minimal chromosome rearrangements. Genes Chromosomes Cancer 12, 272–276 (1995).
  Article CAS PubMed Google Scholar
• Schlegel, J. et al. Comparative genomic in situ hybridization of colon carcinomas with replication error. Cancer Res. 55, 6002–6005 (1995).
  CAS PubMed Google Scholar
• Hedenfalk, I. et al. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344, 539–548 (2001).
  Article CAS PubMed Google Scholar
• Tirkkonen, M. et al. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res. 57, 1222–1227 (1997).
  CAS PubMed Google Scholar
• Wessels, L.F. et al. Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors. Cancer Res. 62, 7110–7117 (2002).
  CAS PubMed Google Scholar
• Slamon, D.J. et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707–712 (1989).
  Article CAS PubMed Google Scholar
• Alitalo, K., Schwab, M., Lin, C.C., Varmus, H.E. & Bishop, J.M. Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc. Natl. Acad. Sci. USA 80, 1707–1711 (1983).
  Article CAS PubMed PubMed Central Google Scholar
• Hinds, P.W., Dowdy, S.F., Eaton, E.N., Arnold, A. & Weinberg, R.A. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA 91, 709–713 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Wahl, G.M., Padgett, R.A. & Stark, G.R. Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells. J. Biol. Chem. 254, 8679–8689 (1979).
  CAS PubMed Google Scholar
• Schimke, R.T., Kaufman, R.J., Alt, F.W. & Kellems, R.F. Gene amplification and drug resistance in cultured murine cells. Science 202, 1051–1055 (1978).
  Article CAS PubMed Google Scholar
• Banerjee, D. et al. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim. Biophys. Acta 1587, 164–173 (2002).
  Article CAS PubMed Google Scholar
• Gorre, M.E. et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293, 876–880 (2001).
  Article CAS PubMed Google Scholar
• Koivisto, P. et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res. 57, 314–319 (1997).
  CAS PubMed Google Scholar
• Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943–1947 (1997).
  Article CAS PubMed Google Scholar
• Orlow, I. et al. Deletion of the p16 and p15 genes in human bladder tumors. J. Natl. Cancer Inst. 87, 1524–1529 (1995).
  Article CAS PubMed Google Scholar
• Nagai, M.A. et al. Detailed deletion mapping of chromosome segment 17q12–21 in sporadic breast tumours. Genes Chromosomes Cancer 11, 58–62 (1994).
  Article CAS PubMed Google Scholar
• Cavenee, W.K. et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305, 779–784 (1983).
  Article CAS PubMed Google Scholar
• Baker, S.J. et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 50, 7717–7722 (1990).
  CAS PubMed Google Scholar
• Ruivenkamp, C.A. et al. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat. Genet. 31, 295–300 (2002).
  Article CAS PubMed Google Scholar
• Snijders, A.M. et al. Shaping tumor and drug resistant genomes by instability and selection. Oncogene 22, 4370–4379 (2003).
  Article CAS PubMed Google Scholar
• Linardopoulos, S., Silva, S., Klein, G. & Balmain, A. Allele-specific loss or imbalance of chromosomes 9, 15, and 16 in B-cell tumors from interspecific F1 hybrid mice carrying Emu-c-myc or N-myc transgenes. Int. J. Cancer. 88, 920–927 (2000).
  Article CAS PubMed Google Scholar
• Hodgson, G. et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet. 29, 459–464 (2001).
  Article CAS PubMed Google Scholar
• Rowley, J.D. The critical role of chromosome translocations in human leukemias. Annu. Rev. Genet. 32, 495–519 (1998).
  Article CAS PubMed Google Scholar
• de Klein, A. et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300, 765–767 (1982).
  Article CAS PubMed Google Scholar
• Davis, R.J., D'Cruz, C.M., Lovell, M.A., Biegel, J.A. & Barr, F.G. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 54, 2869–2872 (1994).
  CAS PubMed Google Scholar
• Galili, N. et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 5, 230–235 (1993).
  Article CAS PubMed Google Scholar
• Massion, P.P. et al. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer Res. 62, 3636–3640 (2002).
  CAS PubMed Google Scholar
• Bekri, S. et al. Detailed map of a region commonly amplified at 11q13–q14 in human breast carcinoma. Cytogenet. Cell Genet. 79, 125–131 (1997).
  Article CAS PubMed Google Scholar
• Hyman, E. et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 62, 6240–6245 (2002).
  CAS PubMed Google Scholar
• Morris, D.W. & Dutra, J.C. Identification of a MMTV insertion mutation within the coding region of the Fgf-3 protooncogene. Virology 238, 161–165 (1997).
  Article CAS PubMed Google Scholar
• Morini, M. et al. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4. Oncogene 19, 6007–6014 (2000).
  Article CAS PubMed Google Scholar
• Quon, K.C. & Berns, A. Haplo-insufficiency? Let me count the ways. Genes Dev. 15, 2917–2921 (2001).
  Article CAS PubMed Google Scholar
• Fero, M.L., Randel, E., Gurley, K.E., Roberts, J.M. & Kemp, C.J. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396, 177–180 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Michel, L.S. et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409, 355–359 (2001).
  Article CAS PubMed Google Scholar
• Herblot, S., Aplan, P.D. & Hoang, T. Gradient of E2A activity in B-cell development. Mol. Cell. Biol. 22, 886–900 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Goss, K.H. et al. Enhanced tumor formation in mice heterozygous for Blm mutation. Science 297, 2051–2053 (2002).
  Article PubMed CAS Google Scholar
• Donehower, L.A. et al. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev. 9, 882–895 (1995).
  Article CAS PubMed Google Scholar
• Shayesteh, L. et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 21, 99–102 (1999).
  Article CAS PubMed Google Scholar
• Willenbucher, R.F. et al. Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. Am. J. Pathol. 154, 1825–1830 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Farag, S.S. et al. Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461. Int. J. Oncol. 21, 1041–1051 (2002).
  CAS PubMed Google Scholar
• Snijders, A.M. et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet. 29, 263–264 (2001).
  Article CAS PubMed Google Scholar
• Zardo, G. et al. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat. Genet. 32, 453–458 (2002).
  Article CAS PubMed Google Scholar
• Cutler, P. Protein arrays: the current state-of-the-art. Proteomics 3, 3–18 (2003).
  Article CAS PubMed Google Scholar
• Bichsel, V.E., Liotta, L.A. & Petricoin, E.F. 3rd. Cancer proteomics: from biomarker discovery to signal pathway profiling. Cancer J. 7, 69–78 (2001).
  CAS PubMed Google Scholar
• van't Veer, L.J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536 (2002).
  Article CAS Google Scholar
• He, J., Olson, J.J. & James, C.D. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res. 55, 4833–4836 (1995).
  CAS PubMed Google Scholar
• He, J. et al. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res. 54, 5804–5807 (1994).
  CAS PubMed Google Scholar
• Bartkova, J. et al. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res. 56, 5475–5483 (1996).
  CAS PubMed Google Scholar
• Namazie, A. et al. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 112, 472–481 (2002).
  Article CAS PubMed Google Scholar
• Lukas, J., Aagaard, L., Strauss, M. & Bartek, J. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. Cancer Res. 55, 4818–4823 (1995).
  CAS PubMed Google Scholar
• Hahn, W.C. et al. Creation of human tumour cells with defined genetic elements. Nature 400, 464–468 (1999).
  Article CAS PubMed Google Scholar
• Zimonjic, D., Brooks, M.W., Popescu, N., Weinberg, R.A. & Hahn, W.C. Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res. 61, 8838–8844 (2001).
  CAS PubMed Google Scholar
• Pelengaris, S., Khan, M. & Evan, G.I. Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109, 321–334 (2002).
  Article CAS PubMed Google Scholar
• Abdel-Rahman, W.M. et al. Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc. Natl. Acad. Sci. USA 98, 2538–2543 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Hartwell, L.H. & Kastan, M.B. Cell cycle control and cancer. Science 266, 1821–8218 (1994).
  Article CAS PubMed Google Scholar
• Gong, G. et al. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin. Cancer Res. 7, 2410–2414 (2001).
  CAS PubMed Google Scholar
• O'Connell, P. et al. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J. Natl. Cancer Inst. 90, 697–703 (1998).
  Article CAS PubMed Google Scholar
• Ried, T. et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15, 234–245 (1996).
  Article CAS PubMed Google Scholar
• Steinbeck, R.G. Chromosome division figures reveal genomic instability in tumorigenesis of human colon mucosa. Br. J. Cancer 77, 1027–1033 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Kuukasjarvi, T. et al. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. Am. J. Pathol. 150, 1465–1471 (1997).
  CAS PubMed PubMed Central Google Scholar
• Waldman, F.M. et al. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J. Natl. Cancer Inst. 92, 313–320 (2000).
  Article CAS PubMed Google Scholar
• Kuukasjarvi, T. et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res. 57, 1597–1604 (1997).
  CAS PubMed Google Scholar
• Yoon, D.S. et al. Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. Am. J. Pathol. 161, 391–397 (2002).
  Article PubMed PubMed Central Google Scholar
• Haber, J.E. DNA recombination: the replication connection. Trends Biochem. Sci. 24, 271–275 (1999).
  Article CAS PubMed Google Scholar
• Wood, R.D., Mitchell, M., Sgouros, J. & Lindahl, T. Human DNA repair genes. Science 291, 1284–1289 (2001).
  Article CAS PubMed Google Scholar
• Khanna, K.K., Lavin, M.F., Jackson, S.P. & Mulhern, T.D. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ. 8, 1052–1065 (2001).
  Article CAS PubMed Google Scholar
• Pierce, A.J. et al. Double-strand breaks and tumorigenesis. Trends Cell Biol. 11, S52–S59 (2001).
  Article CAS PubMed Google Scholar
• van Gent, D.C., Hoeijmakers, J.H. & Kanaar, R. Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet. 2, 196–206 (2001).
  Article CAS PubMed Google Scholar
• Thompson, L.H. & Schild, D. Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat. Res. 477, 131–153 (2001).
  Article CAS PubMed Google Scholar
• Thompson, L.H. & Schild, D. Recombinational DNA repair and human disease. Mutat. Res. 509, 49–78 (2002).
  Article CAS PubMed Google Scholar
• Tibbetts, R.S. et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14, 2989–3002 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Balmain, A. Cancer: new-age tumour suppressors. Nature 417, 235–237 (2002).
  Article CAS PubMed Google Scholar
• Weaver, Z. et al. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Oncogene 21, 5097–5107 (2002).
  Article CAS PubMed Google Scholar
• Jallepalli, P.V. & Lengauer, C. Chromosome segregation and cancer: cutting through the mystery. Nat. Rev. Cancer 1, 109–117 (2001).
  Article CAS PubMed Google Scholar
• D'Assoro, A.B., Lingle, W.L. & Salisbury, J.L. Centrosome amplification and the development of cancer. Oncogene 21, 6146–6153 (2002).
  Article CAS PubMed Google Scholar
• Fisk, H.A., Mattison, C.P. & Winey, M. Centrosomes and tumour suppressors. Curr. Opin. Cell Biol. 14, 700–705 (2002).
  Article CAS PubMed Google Scholar
• Nigg, E.A. Centrosome aberrations: cause or consequence of cancer progression? Nat. Rev. Cancer 2, 815–825 (2002).
  Article CAS PubMed Google Scholar
• Cahill, D.P. et al. Mutations of mitotic checkpoint genes in human cancers. Nature 392, 300–303 (1998).
  Article CAS PubMed Google Scholar
• Nasmyth, K. Segregating sister genomes: the molecular biology of chromosome separation. Science 297, 559–565 (2002).
  Article CAS PubMed Google Scholar
• Hastie, N.D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866–868 (1990).
  Article CAS PubMed Google Scholar
• Rudolph, K.L., Millard, M., Bosenberg, M.W. & DePinho, R.A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 28, 155–159 (2001).
  Article CAS PubMed Google Scholar
• Harrington, L. & Robinson, M.O. Telomere dysfunction: multiple paths to the same end. Oncogene 21, 592–597 (2002).
  Article CAS PubMed Google Scholar
• de Lange, T. Protection of mammalian telomeres. Oncogene. 21, 532–540 (2002).
  Article CAS PubMed Google Scholar
• Forsyth, N.R., Wright, W.E. & Shay, J.W. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation 69, 188–197 (2002).
  Article CAS PubMed Google Scholar
• Gordon, K.E. et al. High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma. Cancer Res. 63, 458–467 (2003).
  CAS PubMed Google Scholar
• Bastian, B.C. et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res. 60, 1968–1973 (2000).
  CAS PubMed Google Scholar
• Greaves, M. Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet. 12, 127–128 (1996).
  Article CAS PubMed Google Scholar
• Maser, R.S. & DePinho, R.A. Connecting chromosomes, crisis, and cancer. Science 297, 565–569 (2002).
  Article CAS PubMed Google Scholar
• Artandi, S.E. & DePinho, R.A. A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr. Opin. Genet. Dev. 10, 39–46 (2000).
  Article CAS PubMed Google Scholar
• Henson, J.D., Neumann, A.A., Yeager, T.R. & Reddel, R.R. Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598–610 (2002).
  Article CAS PubMed Google Scholar
• Poremba, C. et al. Telomerase activity in human proliferative breast lesions. Int. J. Oncol. 12, 641–648 (1998).
  CAS PubMed Google Scholar
• Bednarek, A.K., Sahin, A., Brenner, A.J., Johnston, D.A. & Aldaz, C.M. Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. Clin. Cancer Res. 3, 11–16 (1997).
  CAS PubMed Google Scholar
• Sugino, T. et al. Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates. Int. J. Cancer. 69, 301–306 (1996).
  Article CAS PubMed Google Scholar
• de Lange, T. et al. Structure and variability of human chromosome ends. Mol. Cell Biol. 10, 518–527 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Artandi, S.E. Telomere shortening and cell fates in mouse models of neoplasia. Trends Mol. Med. 8, 44–47 (2002).
  Article CAS PubMed Google Scholar
• Lamprecht, S.A. & Lipkin, M. Migrating colonic crypt epithelial cells: primary targets for transformation. Carcinogenesis 23, 1777–1780 (2002).
  Article CAS PubMed Google Scholar
• Medina, D. Biological and molecular characteristics of the premalignant mouse mammary gland. Biochim. Biophys. Acta 1603, 1–9 (2002).
  CAS PubMed Google Scholar
• Kim, K.M. & Shibata, D. Methylation reveals a niche: stem cell succession in human colon crypts. Oncogene 21, 5441–5449 (2002).
  Article CAS PubMed Google Scholar
• Sokolova, I.A. et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J. Mol. Diagn. 2, 116–123 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Schenk, T. et al. Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients. Chest 111, 1691–1696 (1997).
  Article CAS PubMed Google Scholar
• Ichikawa, D. et al. Analysis of numerical aberrations of specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer. Cancer 77, 2064–2069 (1996).
  Article CAS PubMed Google Scholar
• Gomez Lahoz, E. et al. Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo. Mol. Cell Biol. 19, 353–363 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Bastian, B.C., Wesselmann, U., Pinkel, D. & Leboit, P.E. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J. Invest. Dermatol. 113, 1065–1069 (1999).
  Article CAS PubMed Google Scholar
• Chen, X.Q. et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med. 2, 1033–1035 (1996).
  Article CAS PubMed Google Scholar
• Koshiji, M., Yonekura, Y., Saito, T. & Yoshioka, K. Microsatellite analysis of fecal DNA for colorectal cancer detection. J. Surg. Oncol. 80, 34–40 (2002).
  Article CAS PubMed Google Scholar
• Eisenberger, C.F. et al. Diagnosis of renal cancer by molecular urinalysis. J. Natl. Cancer Inst. 91, 2028–2032 (1999).
  Article CAS PubMed Google Scholar
• Nawroz, H., Koch, W., Anker, P., Stroun, M. & Sidransky, D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med. 2, 1035–1037 (1996).
  Article CAS PubMed Google Scholar
• Utting, M., Werner, W., Dahse, R., Schubert, J. & Junker, K. Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer. Clin. Cancer Res. 8, 35–40 (2002).
  CAS PubMed Google Scholar
• Seeger, R.C. et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 313, 1111–1116 (1985).
  Article CAS PubMed Google Scholar
• Suzuki, S. et al. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res. 60, 5382–5385 (2000).
  CAS PubMed Google Scholar
• Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10869–10874 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• van de Vijver, M.J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999–2009 (2002).
  Article CAS PubMed Google Scholar
• Ramaswamy, S., Ross, K.N., Lander, E.S. & Golub, T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49–54 (2003).
  Article CAS PubMed Google Scholar
• Hanna, W. Testing for HER2 status. Oncology 61, 22–30 (2001).
  Article CAS PubMed Google Scholar
• Vogel, C.L. et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J. Clin. Oncol. 20, 719–726 (2002).
  Article CAS PubMed Google Scholar
• Baselga, J. & Hammond, L.A. HER-targeted tyrosine-kinase inhibitors. Oncology 63 Suppl 1, 6–16 (2002).
  Article CAS PubMed Google Scholar
• Baselga, J. Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist 7 Suppl 4, 2–8 (2002).
  Article CAS PubMed Google Scholar
• Mendelsohn, J. Targeting the epidermal growth factor receptor for cancer therapy. J. Clin. Oncol. 20, 1S–13S (2002).
  Article CAS PubMed Google Scholar
• Levitzki, A. Tyrosine kinases as targets for cancer therapy. Eur. J. Cancer 38 Suppl 5, S11–S18 (2002).
  Article PubMed Google Scholar
• Barlund, M. et al. Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res. 60, 5340–5344 (2000).
  CAS PubMed Google Scholar
• Barlund, M. et al. Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J. Natl. Cancer Inst. 92, 1252–1259 (2000).
  Article CAS PubMed Google Scholar
• Klein, C.A. et al. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc. Natl. Acad. Sci. USA 96, 4494–4499 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Aebi, S. et al. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res. 56, 3087–3090 (1996).
  CAS PubMed Google Scholar
• Albertson, D.G. et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 25, 144–146 (2000).
  Article CAS PubMed Google Scholar
• Jing, J. et al. Automated high resolution optical mapping using arrayed, fluid-fixed DNA molecules. Proc. Natl. Acad. Sci. USA 95, 8046–8051 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949–954 (2002).
  Article CAS PubMed Google Scholar
• Whitfield, M.L. et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell. 13, 1977–2000 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Lipshutz, R.J., Fodor, S.P., Gingeras, T.R. & Lockhart, D.J. High density synthetic oligonucleotide arrays. Nat. Genet. 21, 20–24 (1999).
  Article CAS PubMed Google Scholar
• Heid, C.A., Stevens, J., Livak, K.J. & Williams, P.M. Real time quantitative PCR. Genome Res. 6, 986–994 (1996).
  Article CAS PubMed Google Scholar
• Saha, S. et al. Using the transcriptome to annotate the genome. Nat. Biotechnol. 20, 508–512 (2002).
  Article CAS PubMed Google Scholar
• Yan, H., Yuan, W., Velculescu, V.E., Vogelstein, B. & Kinzler, K.W. Allelic variation in human gene expression. Science 297, 1143 (2002).
  Article CAS PubMed Google Scholar
• Costello, J.F., Plass, C. & Cavenee, W.K. Restriction landmark genome scanning. Methods Mol. Biol. 200, 53–70 (2002).
  CAS PubMed Google Scholar
• Jones, P.A. & Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415–428 (2002).
  Article CAS PubMed Google Scholar
• Knezevic, V. et al. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 1, 1271–1278 (2001).
  Article CAS PubMed Google Scholar
• Paweletz, C.P. et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20, 1981–1989 (2001).
  Article CAS PubMed Google Scholar
• Rubin, R.B. & Merchant, M. A rapid protein profiling system that speeds study of cancer and other diseases. Am. Clin. Lab. 19, 28–29 (2000).
  CAS PubMed Google Scholar
• Iyer, V.R. et al. Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF. Nature 409, 533–538 (2001).
  Article CAS PubMed Google Scholar
• Horak, C.E. et al. GATA-1 binding sites mapped in the β-globin locus by using mammalian chIp-chip analysis. Proc. Natl. Acad. Sci. USA 99, 2924–2929 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Liotta, L. & Petricoin, E. Molecular profiling of human cancer. Nat. Rev. Genet. 1, 48–56 (2000).
  Article CAS PubMed Google Scholar